292 related articles for article (PubMed ID: 19616306)
1. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
Donovan MR; Glue P; Kolluri S; Emir B
J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of relapse prevention antidepressant trials in depressive disorders.
Glue P; Donovan MR; Kolluri S; Emir B
Aust N Z J Psychiatry; 2010 Aug; 44(8):697-705. PubMed ID: 20636190
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of anxious disorders.
Bourin M; Lambert O
Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
[TBL] [Abstract][Full Text] [Related]
4. The pharmacologic treatment of anxiety disorders: a review of progress.
Ravindran LN; Stein MB
J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
[TBL] [Abstract][Full Text] [Related]
5. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
Bech P; Lönn SL; Overø KF
J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
[TBL] [Abstract][Full Text] [Related]
6. Anxiety disorders in schizophrenia.
Braga RJ; Petrides G; Figueira I
Compr Psychiatry; 2004; 45(6):460-8. PubMed ID: 15526257
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
8. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
9. Impact of study design on the results of continuation studies of antidepressants.
Zimmerman M; Posternak MA; Ruggero CJ
J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
[TBL] [Abstract][Full Text] [Related]
10. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.
Batelaan NM; Bosman RC; Muntingh A; Scholten WD; Huijbregts KM; van Balkom AJLM
BMJ; 2017 Sep; 358():j3927. PubMed ID: 28903922
[No Abstract] [Full Text] [Related]
11. Efficacy in long-term treatment of depression.
Montgomery SA
J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
Sugarman MA; Kirsch I; Huppert JD
J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
14. Anxious depression.
Lydiard RB; Brawman-Mintzer O
J Clin Psychiatry; 1998; 59 Suppl 18():10-7. PubMed ID: 9840193
[TBL] [Abstract][Full Text] [Related]
15. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
Roshanaei-Moghaddam B; Pauly MC; Atkins DC; Baldwin SA; Stein MB; Roy-Byrne P
Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacologic treatment of panic, generalized anxiety disorder, and social phobia.
Roy-Byrne P; Wingerson D; Cowley D; Dager S
Psychiatr Clin North Am; 1993 Dec; 16(4):719-35. PubMed ID: 8309809
[TBL] [Abstract][Full Text] [Related]
18. Long-term goals in the management of acute and chronic anxiety disorders.
Kjernisted KD; Bleau P
Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):51S-63S. PubMed ID: 15147036
[TBL] [Abstract][Full Text] [Related]
19. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
20. Let's talk facts about anxiety disorders.
American Psychiatric Association
J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
